Worth reading
54Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
116000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of the 27th and 28th series of stock acquisition rights as stock-based compensation stock options
Who receives how much
27th series of stock acquisition rights 21,300 shares / 28th series of stock acquisition rights 94,700 shares / Total 116,000 shares
3 directors of the Company151 rights
3 of the Company’s audit & supervisory board members62 rights
27 employees of the Company947 rights
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
The payment amount per stock acquisition right will be the fair value calculated using the Black-Scholes model on the allotment date.
Total Stock-Based Compensation
Monetary compensation equivalent to the total payment amount for the share acquisition rights will be paid, but the amount is Not disclosed.
Terms of the stock acquisition rights
Exercise price
¥1 per share. No adjustment provisions are specified
Exercise period
27th series of stock acquisition rights Start Date 26 August 2029 / End date 25 August 2031 / 28th series of stock acquisition rights Start Date 26 August 2028 / End date 25 August 2030
Number of Stock Acquisition Rights
Total number issued 27th series 213 rights / 28th series 947 rights / Unexercised balance Not disclosed
Reason for acquisition without consideration
If approval is given at a shareholders’ meeting, or by a resolution of the Board of Directors where shareholder approval is not required, for a merger agreement under which the Company is the disappearing company, a corporate demerger agreement or plan under which the Company is the demerged company, or a share exchange agreement or share transfer plan under which the Company becomes a wholly owned subsidiary, the Company may acquire all of the stock acquisition rights without consideration upon the arrival of a date separately determined by the Board of Directors, If, before exercising the rights, a holder of the stock acquisition rights becomes unable to exercise them under the exercise conditions, the Company may acquire the rights for no consideration.
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 3 / Number of allocated shares 15,100 shares, Category Our Audit & Supervisory Board member / Number of Employees 3 / Number of allocated shares 6,200 shares, Category The Company's employees / Number of Employees 27 / Number of allocated shares 94,700 shares
Payment date
25 August 2026
Basis for determining the amount to be paid
The payment amount for the stock acquisition rights will be the fair value calculated using the Black-Scholes model on the allotment date
Procedures under the Corporate Code of Conduct
The issuance was approved at a Board of Directors meeting held on 7 August 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 27th and 28th series of stock acquisition rights as stock-based compensation stock options |
| Number of shares to be issued or disposed of | 27th series of stock acquisition rights 21,300 shares / 28th series of stock acquisition rights 94,700 shares / Total 116,000 shares |
| Issue price and disposal price | The payment amount per stock acquisition right will be the fair value calculated using the Black-Scholes model on the allotment date. |
| Payment date | 25 August 2026 |
| Intended allottee | Category 3 directors of the Company / Number of units 151 rights, Category 3 of the Company’s audit & supervisory board members / Number of units 62 rights, Category 27 employees of the Company / Number of units 947 rights |
| Basis for determining the amount to be paid | The payment amount for the stock acquisition rights will be the fair value calculated using the Black-Scholes model on the allotment date |
| Exercise price | ¥1 per share. No adjustment provisions are specified |
| Exercise period | 27th series of stock acquisition rights Start Date 26 August 2029 / End date 25 August 2031 / 28th series of stock acquisition rights Start Date 26 August 2028 / End date 25 August 2030 |
| Number of Stock Acquisition Rights | Total number issued 27th series 213 rights / 28th series 947 rights / Unexercised balance Not disclosed |
| Reason for acquisition without consideration | If approval is given at a shareholders’ meeting, or by a resolution of the Board of Directors where shareholder approval is not required, for a merger agreement under which the Company is the disappearing company, a corporate demerger agreement or plan under which the Company is the demerged company, or a share exchange agreement or share transfer plan under which the Company becomes a wholly owned subsidiary, the Company may acquire all of the stock acquisition rights without consideration upon the arrival of a date separately determined by the Board of Directors, If, before exercising the rights, a holder of the stock acquisition rights becomes unable to exercise them under the exercise conditions, the Company may acquire the rights for no consideration. |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 3 / Number of allocated shares 15,100 shares, Category Our Audit & Supervisory Board member / Number of Employees 3 / Number of allocated shares 6,200 shares, Category The Company's employees / Number of Employees 27 / Number of allocated shares 94,700 shares |
| Total Stock-Based Compensation | Monetary compensation equivalent to the total payment amount for the share acquisition rights will be paid, but the amount is Not disclosed. |
| Procedures under the Corporate Code of Conduct | The issuance was approved at a Board of Directors meeting held on 7 August 2026 |
Items this document does not state (15)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To share with shareholders not only the benefits of a rising share price but also the risk of a decline, increase incentives for directors and employees to improve performance, raise audit & supervisory board members’ awareness of the importance of conducting appropriate audits, and promote sound management.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.